Section of Transplantation and Immunology, Department of Surgery, Yale University School of Medicine, Yale-New Haven Transplantation Center, New Haven, Connecticut.
JAMA Surg. 2014 Jan;149(1):63-70. doi: 10.1001/jamasurg.2013.3384.
The use of technically variant segmental grafts are key in offering transplantation to increase organ availability.
To describe the use of segmental allograft in the current era of donor scarcity, minimizing vascular complications using innovative surgical techniques.
DESIGN, SETTING, AND PARTICIPANTS: Retrospective study from August 2007 to August 2012 at a university hospital. A total of 218 consecutive liver transplant patients were reviewed, and 69 patients (31.6%; 38 males and 31 females; mean age, 22.5 years) received segmental grafts from living donors or split/reduced-size grafts from deceased donors.
Graft type, vascular and biliary complications, and patient and graft survival.
Of 69 segmental transplants, 47 were living donor liver transplants: 13 grafts (27.7%) were right lobes, 22 (46.8%) were left lobes, and 12 (25.5%) were left lateral segments. Twenty-two patients received deceased donor segmental grafts; of these, 11 (50.0%) were extended right lobes, 9 (40.9%) were left lateral segments, 1 (4.5%) was a right lobe, and 1 (4.5%) was a left lobe. Arterial anastomoses were done using 8-0 monofilament sutures in an interrupted fashion for living donor graft recipients and for pediatric patients. Most patients received a prophylactic dose of low-molecular-weight heparin for a week and aspirin indefinitely. There was no incidence of hepatic artery or portal vein thrombosis. Two patients developed hepatic artery stenosis and were treated with balloon angioplasty by radiology. Graft and patient survivals were 96% and 98%, respectively.
Use of segmental allografts is essential to offer timely transplantation and decrease waiting list mortality. Living donor liver transplants and segmental grafts from deceased donors are complementary. It is possible to have excellent outcomes combining a multidisciplinary team approach, technical expertise, routine use of anticoagulation, and strict patient and donor selection.
使用技术上不同的节段移植物是提供移植以增加器官可用性的关键。
描述在供体短缺的当前时代使用节段同种异体移植物,通过创新的手术技术最大限度地减少血管并发症。
设计、地点和参与者:2007 年 8 月至 2012 年 8 月在一所大学医院进行的回顾性研究。共回顾了 218 例连续肝移植患者,其中 69 例(31.6%;38 名男性和 31 名女性;平均年龄 22.5 岁)接受了来自活体供体的节段移植物或来自已故供体的分割/减小体积的移植物。
移植物类型、血管和胆道并发症以及患者和移植物存活率。
在 69 例节段移植中,47 例为活体供体肝移植:13 例(27.7%)为右叶,22 例(46.8%)为左叶,12 例(25.5%)为左外侧叶。22 例患者接受了已故供体节段移植;其中,11 例(50.0%)为扩展右叶,9 例(40.9%)为左外侧叶,1 例(4.5%)为右叶,1 例(4.5%)为左叶。活体供体移植物受体和儿科患者的动脉吻合采用 8-0 单丝缝线间断缝合。大多数患者接受了一周的低分子量肝素预防性剂量和无限期的阿司匹林。无肝动脉或门静脉血栓形成的发生。2 例患者发生肝动脉狭窄,经放射科球囊血管成形术治疗。移植物和患者存活率分别为 96%和 98%。
使用节段同种异体移植物对于提供及时的移植和降低等待名单死亡率至关重要。活体供体肝移植和已故供体的节段移植物是互补的。结合多学科团队方法、技术专长、常规使用抗凝剂以及严格的患者和供体选择,可以取得优异的结果。